Sequential administration of OKT3 (anti-CD3) and interleukin-2 in two patients with chemoresistant hematological disease.
Massaia
M
M
Bianchi
A
A
Peola
S
S
Borrione
P
P
Attisano
C
C
Pileri
A
A
D000328:Adult; D004334:Drug Administration Schedule; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D005260:Female; D006402:Hematologic Diseases / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D007376:Interleukin-2 / Q000627:therapeutic use*; D016853:Muromonab-CD3 / Q000627:therapeutic use*
D007376:Interleukin-2; D016853:Muromonab-CD3